Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Jim Cramer: This Company Is 'Arranging Deck Chairs On The Titanic... Not A Believer'

Published 06/10/2023, 14:08
Updated 06/10/2023, 15:10
© Reuters.  Jim Cramer: This Company Is 'Arranging Deck Chairs On The Titanic... Not A Believer'

Benzinga - by Priya Nigam, Benzinga Staff Writer.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Topgolf Callaway Brands Corp. (NYSE: MODG) is making money. "I think it’s a great experiential situation, but I have been wrong,” he added.

When asked about Under Armour, Inc. (NYSE: UA), he said, "We got to see something, we got to see a good quarter. We have to see something that tells me that Stephanie Linnartz is doing a good job." He added, "I don’t have enough data to make me say buy it."

Cramer said Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is excellent. "That is an amazing company," he added.

"It’s almost like they’re arranging the deck chairs on the Titanic," Cramer said when asked about BlackBerry Limited (NYSE: BB). "I’m not going there, I’m not a believer."

Don’t forget to check out our premarket coverage here

When asked about Sabre Corporation (NASDAQ: SABR), he said, "I think BKNG is the stock that you want to be in, not SABR."

Cramer recommends not buying any more of Shopify Inc. (NYSE: SHOP) right now. "I think we have to wait for it to come down to buy more," he added.

Kyndryl Holdings, Inc. (NYSE: KD) is "doing quite well, that last quarter was good, I think we’re going to get rid of the overhang, start seeing some great numbers," Cramer said.

Price Action: Shares of Kyndryl fell 0.5% to close at $15.02, while Shopify lost 0.7% to $52.19 on Thursday. Sabre settled at $3.84, while BlackBerry fell 11.2% to close at $3.79 on Thursday. Vertex shares rose 0.6% to close at $355.14, while Under Armour fell 0.5% to settle at $6.11 on Thursday. Shares of Topgolf Callaway Brands slipped 0.3% to close at $13.41 on Thursday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying

Image: Shutterstock

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.